Business Description
Clene Inc
NAICS : 311999
SIC : 2834
ISIN : US1856341029
Share Class Description:
CLNN: Ordinary SharesDescription
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.64 | |||||
| Equity-to-Asset | -0.13 | |||||
| Debt-to-Equity | -5.55 | |||||
| Debt-to-EBITDA | -0.77 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -14.8 | |||||
| Beneish M-Score | -5.29 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -19 | |||||
| 3-Year EBITDA Growth Rate | 24.8 | |||||
| 3-Year EPS without NRI Growth Rate | 19.1 | |||||
| 3-Year FCF Growth Rate | 35.9 | |||||
| 3-Year Book Growth Rate | 162.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 42.71 | |||||
| Future 3-5Y Total Revenue Growth Rate | 250.93 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 41.64 | |||||
| 9-Day RSI | 36.32 | |||||
| 14-Day RSI | 37.5 | |||||
| 6-1 Month Momentum % | -23.79 | |||||
| 12-1 Month Momentum % | -41.85 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.83 | |||||
| Quick Ratio | 0.82 | |||||
| Cash Ratio | 0.61 | |||||
| Days Inventory | 278.21 | |||||
| Days Sales Outstanding | 93.63 | |||||
| Days Payable | 6312.07 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -29.2 | |||||
| Shareholder Yield % | 6.19 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 78.62 | |||||
| Operating Margin % | -7908.08 | |||||
| Net Margin % | -8556.77 | |||||
| FCF Margin % | -5627.08 | |||||
| ROE % | -523.13 | |||||
| ROA % | -78.4 | |||||
| ROIC % | -100.63 | |||||
| ROC (Joel Greenblatt) % | -242.69 | |||||
| ROCE % | -140.8 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 61.67 | |||||
| EV-to-EBIT | -1.25 | |||||
| EV-to-Forward-EBIT | -1.04 | |||||
| EV-to-EBITDA | -1.32 | |||||
| EV-to-Forward-EBITDA | -1.07 | |||||
| EV-to-Revenue | 93.1 | |||||
| EV-to-Forward-Revenue | 91.89 | |||||
| EV-to-FCF | -1.65 | |||||
| Earnings Yield (Greenblatt) % | -80 | |||||
| FCF Yield % | -71.54 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CLNN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Clene Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.421 | ||
| EPS (TTM) ($) | -5.37 | ||
| Beta | 0.79 | ||
| Volatility % | 103.28 | ||
| 14-Day RSI | 37.5 | ||
| 14-Day ATR ($) | 0.486428 | ||
| 20-Day SMA ($) | 4.9695 | ||
| 12-1 Month Momentum % | -41.85 | ||
| 52-Week Range ($) | 3.8181 - 12 | ||
| Shares Outstanding (Mil) | 7.98 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Clene Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Clene Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Clene Inc Frequently Asked Questions
What is Clene Inc(CLNN)'s stock price today?
The current price of CLNN is $4.15. The 52 week high of CLNN is $12.00 and 52 week low is $3.82.
When is next earnings date of Clene Inc(CLNN)?
The next earnings date of Clene Inc(CLNN) is 2025-03-13 Est..
Does Clene Inc(CLNN) pay dividends? If so, how much?
Clene Inc(CLNN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers